Vitamin D During In Vitro Fertilisation (IVF) - A Prospective Randomized Trial

Phase 3UnknownNCT01019785

Karolinska University Hospital1,000 enrolled

Overview

During IVF treatment women will be randomized into supplementation with a high or a low dose of Vitamin D Main outcome Laboratory pregnancy, live pregnancy at 12 weeks, Baby take home rate, OHSS Secondary outcome: 1. Pregnancy complications (pregnancy hypertension, SGA, Diabetes) 2.Thrombin generation

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

QUADRUPLE

Enrollment

1,000

Conditions

Pregnancy Complication

Interventions

ErgocalciferolDIETARY_SUPPLEMENT

100 000 U drops is given once

ErgocalciferolDIETARY_SUPPLEMENT

500 U drops given once

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All women initiating IVF treatment Exclusion Criteria: * Women that have entered the study before

Locations (1)

IVF Unit Karolinska University Hospital, Huddinge

Huddinge, Sweden

Outcomes

Primary Outcomes

Laboratory pregnancy, live pregnancy at 12 weeks, take home baby rate

Time frame: 4 weeks to 9 month

Secondary Outcomes

Pregnancy complications (pregnancy hypertension, SGA, diabetes)

Time frame: 9 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.